Imprimir Ver referencias Citación Disclaimer: These citations have been automatically generated based on the information we have and it may not be 100% accurate. Please consult the latest official manual style if you have any questions regarding the format accuracy. AMA Citation Lennon J, Ramjaun A. Lennon J, & Ramjaun A Lennon, Jack, and Aliya Ramjaun. Association of Use of Oral Contraceptives With Depressive Symptoms Among Adolescents and Young Women. 2 Minute Medicine, 18 febrero 2020. McGraw-Hill, 2020. AccessMedicina. https://accessmedicina.mhmedical.com/updatesContent.aspx?gbosid=532263§ionid=239811767APA Citation Lennon J, Ramjaun A. Lennon J, & Ramjaun A Lennon, Jack, and Aliya Ramjaun. (2020). Association of use of oral contraceptives with depressive symptoms among adolescents and young women. (2020). 2 minute medicine. McGraw-Hill. https://accessmedicina.mhmedical.com/updatesContent.aspx?gbosid=532263§ionid=239811767.MLA Citation Lennon J, Ramjaun A. Lennon J, & Ramjaun A Lennon, Jack, and Aliya Ramjaun. "Association of Use of Oral Contraceptives With Depressive Symptoms Among Adolescents and Young Women." 2 Minute Medicine McGraw-Hill, 2020, https://accessmedicina.mhmedical.com/updatesContent.aspx?gbosid=532263§ionid=239811767. Descargar archivo de la citación: RIS (Zotero) EndNote BibTex Medlars ProCite RefWorks Reference Manager Mendeley © Copyright Clip Capítulo completo Sólo figuras Sólo cuadros Solo Videos Supplementary Content Arriba Association of Use of Oral Contraceptives With Depressive Symptoms Among Adolescents and Young Women by Jack Lennon, Aliya Ramjaun Listen +Originally published by 2 Minute Medicine® (view original article). Reused on AccessMedicine with permission. +1. Adolescent females using oral contraceptives may be at an increased risk of concurrent depressive symptoms. +Evidence Rating Level: 1 (Excellent) +Previous studies have indicated that oral contraceptive use may be associated with an increased risk of future depressive symptoms. However, the risk of concurrent depressive symptoms has not been well established. Using data from waves 3-6 (n=1,010) of the Tracking Adolescents’ Individual Lives Survey (TRAILS), investigators conducted a prospective cohort study, evaluating the association between oral contraceptive use and depressive symptoms in youth using oral contraceptives at the ages of 16, 19, 22, and 25 years. Nonusers of oral contraceptives differed significantly from users at 16 years of age by mean socioeconomic status (difference 0.32). In assessing all oral contraceptive users, researchers found no significant differences in depressive symptom scores when compared to nonusers. However, adolescent-aged users reported significantly higher depressive symptom scores than their same-aged nonusers, which maintained significance after adjusting for socioeconomic status, ethnicity, and age (p=0.0096). Compared to nonusers, this adolescent group also reported more eating problems (OR 1.54 95% CI 1.13 to 2.10, p=0.009), hypersomnia (OR 1.68, 95% CI 1.14 to 2.48, p<0.001), and crying (OR 1.89, 95% CI 1.89, 95% CI 0.038 to -0.005, p=0.0096). This study suggests that, while concurrent depressive symptoms may not be associated with all age groups, oral contraceptive use among adolescents may be associated with increased depressive symptoms. As such, it is important that mood symptoms are adequately monitored in this vulnerable population when oral contraceptives are being used. +Click to read the study in JAMA Psychiatry +©2019 2 Minute Medicine, Inc. All rights reserved. No works may be reproduced without expressed written consent from 2 Minute Medicine, Inc. Inquire about licensing here. No article should be construed as medical advice and is not intended as such by the authors or by 2 Minute Medicine, Inc.